Mutations in the ghrelin receptor gene GHSR in congenital hypopituitarism
https://doi.org/10.14341/probl201763298-102
Abstract
The results of molecular genetic studies indicate the potential involvement of ghrelin in the pathogenesis of some dwarfism forms. However, in the case of isolated somatotropin insufficiency, mutations in the ghrelin receptor gene are a rare cause of the disease. The article describes a case of identification, based on new generation sequencing (NGS) using the AmpliSeq technology, of a functionally significant marker ― the c.837C>A substitution in the ghrelin receptor gene GHSR (OMIM: 615925) in the heterozygous state in two sisters with isolated growth hormone deficiency and the clinical picture of malabsorption syndrome. We have supposed that mutations in the GHSR gene may be an etiological factor of isolated somatotropin insufficiency in a combination with malabsorption syndrome and eating disorders. Mutations in the GHSR gene enable predicting the development of somatotropin insufficiency not associated with abnormality of other pituitary hormones.
About the Authors
Elena B. BashninaNorth-Western State Medical University named after I.I. Mechnikov
Russian Federation
MD, PhD, Professor
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Olga S. Berseneva
North-Western State Medical University named after I.I. Mechnikov
Russian Federation
MD
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Andrey S. Glotov
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
PhD
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Oleg S. Glotov
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
PhD
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Mariia E. Turkunova
Children Endocrinology center
Russian Federation
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Elena A. Serebryakova
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
Vladislav S. Baranov
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
Russian Federation
MD, PhD, Professor
Competing Interests:
Авторы декларируют отсутствие явных и потенциальных конфликтов интересов, связанных с публикацией настоящей статьи.
References
1. Murray PG, Higham CE, Clayton PE. 60 years of neuroendocrinology: The hypothalamo-GH axis: the past 60 years. J Endocrinol. 2015;226(2):T123-140. doi: 10.1530/JOE-15-0120.
2. Papotti M, Ghe C, Cassoni P et al. Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab. 2000;85(10):3803-3807. doi: 10.1210/jcem.85.10.6846.
3. Волков В.П. Новые панкреатические гормоны: грелин (обзор литературы). // Universum: Медицина и фармакология. — 2014. — №12. [Volkov VP. New pancreatic hormones: ghrelin (review of literature). Universum: Meditsina i farmakologiya. 2014;(12). (In Russ).] Доступно по: http://7universum.com/en/med/archive/item/1797. Ссылка активна на 20.03.2016.
4. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun. 2000;279(3):909-913. doi: 10.1006/bbrc.2000.4039.
5. Yin Y, Li Y, Zhang W. The growth hormone secretagogue receptor: its intracellular signaling and regulation. Int J Mol Sci. 2014;15(3):4837-4855. doi: 10.3390/ijms15034837.
6. Никонова Л.В., Давыдчик Э.В. Грелин: физиологические аспекты действия. // Журнал Гродненского государственного медицинского университета. — 2013. — №3. — С. 23—25. [Nikonova LV, Davydchik EV. Ghrelin: physiological aspects of action. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 2013;(3):23-25. (In Russ).]
7. Кириенкова Е.В., Литвинова Л.С., Селедцов В.И. и др. Метаболические и сердечно-сосудистые эффекты грелина. // Ожирение и метаболизм. — 2012. — Т. 9. — №1. — С. 3—8. [Kirienkova EV, Litvinova LS, Seledtsov VI, et al. Metabolic and cardiovascular effects of ghrelin. Obesity and metabolism. 2012;9(1):3-8. (In Russ).] doi: 10.14341/2071-8713-5048
8. Cruz CR, Smith RG. The growth hormone secretagogue receptor. Vitam Horm. 2008;77:47-88. doi: 10.1016/S0083-6729(06)77004-2.
9. Muller TD, Tschop MH. Ghrelin — a key pleiotropic hormone-regulating systemic energy metabolism. Endocr Dev. 2013;25:91-100. doi: 10.1159/000346590.
10. Nass R. Growth hormone axis and aging. Endocrinol Metab Clin North Am. 2013;42(2):187-199. doi: 10.1016/j.ecl.2013.02.001.
11. Stylianou C, Galli-Tsinopoulou A, Grammatikopoulou MG et al. Ghrelin and growth hormone serum levels during the clonidine test in children with short stature and variable growth hormone status. Hormones (Athens). 2011;10(1):39-45. doi:10.14310/horm.2002.1291
12. Davenport AP, Holst B et al. Ghrelin receptor, introduction. [Internet]. Guide to pharmacology [updated 2015 August 10; cited 2016 March 15]. Available from: http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=28.
13. Pantel J, Legendre M, Nivot S et al. Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J Clin Endocrinol Metab. 2009;94(11):4334-4341. doi: 10.1210/jc.2009-1327.
14. Glotov AS, Kazakov SV, Zhukova EA et al. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group. Clin Chim Acta. 2015;446:132-140. doi: 10.1016/j.cca.2015.04.014.
15. Wang HJ, Geller F, Dempfle A et al. Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J Clin Endocrinol Metab. 2004;89(1):157-162. doi: 10.1210/jc.2003-031395.
16. Pugliese-Pires PN, Fortin JP, Zhu Y et al. Novel Mutations in the Growth Hormone Secretagogue Receptor Gene (GHSR) Associated with Constitutional Delay in Growth and Puberty (CDGP). Oral Sessions II [Internet]. The Endocrine Society. 2010:OR35—3—OR35—3. doi: 10.1210/endo-meetings.2010.part3.or2.or35-3
17. Feighner SD, Howard AD, Prendergast K et al. Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues. Mol Endocrinol. 1998;12(1):137-145. doi: 10.1210/mend.12.1.0051.
Supplementary files
|
1. Рис. 1. Значение SDS роста в зависимости от возраста, пациентка Д. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(16KB)
|
Indexing metadata ▾ |
|
2. Рис. 2. Значение SDS роста в зависимости от возраста, пациентка И. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(17KB)
|
Indexing metadata ▾ |
Review
For citations:
Bashnina E.B., Berseneva O.S., Glotov A.S., Glotov O.S., Turkunova M.E., Serebryakova E.A., Baranov V.S. Mutations in the ghrelin receptor gene GHSR in congenital hypopituitarism. Problems of Endocrinology. 2017;63(2):98-102. https://doi.org/10.14341/probl201763298-102

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).